Description
isoproterenol · CAS 7683-59-2 · C11H17NO3. UNII L628TT009W. Melting Point: 180; Melting Point: 170.5 °C; Solubility: 5.86e+00 g/L.
Identification
| CAS Registry Number | 7683-59-2 |
|---|
| PubChem CID | 3779 |
|---|
| Molecular formula | C11H17NO3 |
|---|
| IUPAC name | 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol |
|---|
| UNII (FDA) | L628TT009W |
|---|
Computed Descriptors
| Molecular Weight | 211.26 |
|---|
| XLogP3 | -0.6 |
|---|
| Hydrogen Bond Donor Count | 4 |
|---|
| Hydrogen Bond Acceptor Count | 4 |
|---|
| Rotatable Bond Count | 4 |
|---|
| Exact Mass | 211.12084340 |
|---|
| Monoisotopic Mass | 211.12084340 |
|---|
| Topological Polar Surface Area | 72.7 |
|---|
| Heavy Atom Count | 15 |
|---|
| Formal Charge | 0 |
|---|
Physical & Chemical Properties
| Melting Point | 180 |
|---|
| Melting Point | 170.5 °C |
|---|
| Solubility | 5.86e+00 g/L |
|---|
| LogP | 1.4 |
|---|
| LogP | -0.61 |
|---|
| Dissociation Constants | 8.65 |
|---|
Physical description & handling notes
- Solid
- 151.0 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID6025486]
- 151.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID6025486]
- 147.87 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
- 149.95 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
- 148.27 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Documented Uses
- For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitis
- Isoproterenol, also known as isoprenaline, is a nonselective beta-adrenoceptor agonist. The drug is used to treat bradydysrhythmias and to evaluate electrophysiology in a supervised clinical setting. Structurally, the drug resembles epinephrine. Isoproterenol was first approved by the US Food and Drug Administration (FDA) for use in the United States in 1947. Both FDA-approved and off-label indications for isoproterenol are mentioned below.
- Drugs that selectively bind to and activate beta-adrenergic receptors.
- Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
- Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
- Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Synonyms
isoproterenol; Isoprenaline; 7683-59-2; Isopropydrin; Aludrine; Novodrin; Asiprenol; Assiprenol; Bellasthman; Isoprenalin; Respifral; Asmalar; Neodrenal; Proternol; neo-Epinine; Isonorin
Frequently Asked Questions
What are the CAS number and molecular formula of isoproterenol?
CAS 7683-59-2; molecular formula C11H17NO3; molecular weight — g/mol.
What other names is isoproterenol known by?
isoproterenol, Isoprenaline, 7683-59-2, Isopropydrin, Aludrine, Novodrin.
What are the key physical properties of isoproterenol?
Melting Point: 180; Melting Point: 170.5 °C; Solubility: 5.86e+00 g/L; LogP: 1.4.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.
